Hepion Pharmaceuticals Files 8-K on Security Holder Rights
Ticker: CTRVP · Form: 8-K · Filed: Mar 19, 2025 · CIK: 1583771
| Field | Detail |
|---|---|
| Company | Hepion Pharmaceuticals, Inc. (CTRVP) |
| Form Type | 8-K |
| Filed Date | Mar 19, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, legal-filing
TL;DR
Hepion Pharma 8-K filed: changes to security holder rights and bylaws effective March 17.
AI Summary
Hepion Pharmaceuticals, Inc. filed an 8-K on March 19, 2025, reporting material modifications to security holder rights and amendments to its articles of incorporation or bylaws, effective March 17, 2025. The filing also includes financial statements and exhibits.
Why It Matters
This filing indicates potential changes in the rights associated with Hepion Pharmaceuticals' securities, which could impact investors and their holdings.
Risk Assessment
Risk Level: medium — Changes to security holder rights and bylaws can introduce new risks or alter existing ones for investors.
Key Players & Entities
- Hepion Pharmaceuticals, Inc. (company) — Registrant
- March 17, 2025 (date) — Effective date of changes
- March 19, 2025 (date) — Filing date
- ContraVir Pharmaceuticals, Inc. (company) — Former company name
FAQ
What specific modifications were made to the rights of security holders?
The filing indicates material modifications to the rights of security holders, but the specific details of these modifications are not elaborated upon in the provided text.
What amendments were made to the articles of incorporation or bylaws?
The filing states that there were amendments to the articles of incorporation or bylaws, but the specific nature of these amendments is not detailed in the provided text.
When were the reported changes effective?
The earliest event reported, which includes the material modifications and amendments, was effective as of March 17, 2025.
What is the primary business of Hepion Pharmaceuticals, Inc.?
Hepion Pharmaceuticals, Inc. is in the business of Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].
Has Hepion Pharmaceuticals, Inc. operated under a different name previously?
Yes, Hepion Pharmaceuticals, Inc. was formerly known as ContraVir Pharmaceuticals, Inc., with a date of name change on August 6, 2013.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding Hepion Pharmaceuticals, Inc. (CTRVP).